Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
Company Announcements
Replimune Group Reports Increased Losses Amid R&D Expansion
3d ago
REPL
Premium
Ratings
Positive Outlook for Replimune Group: Buy Rating Affirmed on Promising RP1 + Opdivo Therapy and Strong Financial Position
3d ago
REPL
Premium
The Fly
Replimune reports Q2 EPS (90c), consensus (79c)
3d ago
REPL
Premium
The Fly
Replimune upgraded to Market Perform from Underperform at BMO Capital
7d ago
REPL
Premium
Ratings
Replimune Group’s RP1 Resubmission Boosts Approval Odds and Buy Rating
14d ago
REPL
Premium
The Fly
Replimune upgraded to Buy from Neutral at H.C. Wainwright
14d ago
REPL
Premium
The Fly
Genelux price target raised to $20 from $10 at Maxim
19d ago
GNLX
REPL
Premium
Ratings
Cautious Outlook on Replimune Group Amid FDA Uncertainties and Potential Risks
19d ago
REPL
Premium
The Fly
Piper upgrades Replimune to Overweight on ‘very pleasant surprise’
20d ago
REPL
Premium
The Fly
Replimune upgraded to Overweight from Neutral at Piper Sandler
20d ago
REPL
Premium
Company Announcements
Replimune Group’s FDA Resubmission for RP1 Accepted
20d ago
8K
REPL
Premium
The Fly
Replimune upgraded to Neutral from Underweight at JPMorgan
20d ago
REPL
Premium
The Fly
Replimune upgraded to Neutral at JPMorgan after BLA resubmission accepted
20d ago
REPL
Premium
The Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
20d ago
BA
DX
Premium
The Fly
Leerink upgrades Replimune on renewed confidence in RP1
20d ago
REPL
Premium
The Fly
Replimune upgraded to Outperform from Market Perform at Leerink
20d ago
REPL
Premium
The Fly
Unusually active option classes on open October 20th
20d ago
AUR
CAN
Premium
The Fly
Wedbush upgrades Replimune to Outperform amid second BLA review
20d ago
REPL
Premium
The Fly
Replimune upgraded to Outperform from Neutral at Wedbush
20d ago
REPL
Premium
The Fly
Replimune announces FDA acceptance of BLA resubmission of RP1
20d ago
REPL
Premium
The Fly
Replimune announces new ad hoc analysis from IGNYTE phase 2 cohort of RP1
21d ago
REPL
Premium
The Fly
Intel downgraded, Tesla upgraded: Wall Street’s top analyst calls
2M ago
CVX
MET
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
